Long COVID-19 and central sensitivity syndrome

Currently, there is still no clear definition of persistent COVID or “Long COVID”. Generally, it is a disease described in patients who have had COVID-19 and who continue to show symptoms for longer than expected. Among various clinical manifestations, the symptoms of persistent COVID-19 include musculoskeletal symptoms such as myalgia, joint pain and fatigue. Manifestations present in people affected by central sensitivity syndrome. Bearing in mind this symptomatology could get worse in these patients if they suffer from persistent COVID, we present the situation of a woman with a history of fibromyalgia and chronic fatigue syndrome who presents a worsening of the symptomatology produced by her illnesses, after suffering from COVID-19. This case raises the question of whether the aggravation suffered by the patient was caused by the viral infection or by the impact on her state of mind caused by the pandemic situation. The persistence of musculoskeletal symptoms in people who have suffered from COVID-19 should be studied extensively and with special emphasis on those affected by any of the pathologies included in the central sensitivity syndrome. © 2021 The Author(s)

COVID-19 and intracranial hemorrhage

COVID-19 is the disease caused by a new coronavirus originated in Wuhan (Hubei province in China) in December 2019, called SARS-CoV-2. It is currently responsible for a global pandemic declared on March 11, 2020 by the World Health Organization (WHO). Taking into account that patients with severe COVID-19 are more likely to suffer neurological symptoms, we expose a case of a hypertensive patient who has been found unconscious in the public thoroughfare. He presented right cerebellar intraparenchymal hematoma with an arteriovenous malformation and smear nasopharyngeal test positive for SARS-CoV-2. The case that we present creates the dilemma of whether the clinical picture presented by the patient is chance or causality. The SARS-CoV-2 infection could have contributed to brain hemorrhage since the new coronavirus affects the neurological system and high blood pressure is considered a risk factor for the severe evolution of COVID-19. Several cases with COVID-19 complicated by intracranial hemorrhages have been described;however, it will be necessary to carry out relevant studies to confirm this association. © 2020 The Authors